Product Information
ACYCLOVIR 200 MG/5 ML SUSP is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.0764 per ML under NDC 70954018810. Its NADAC has been published 317 times since Sep 9, 2020.
FDA first approved this application on Jul 10, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/5mL
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954018810
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACYCLOVIRApproval Type
Generic (ANDA)
FDA Application
ANDA212252FDA Approved
7/10/2020
TE Code
AB
On Market Since
7/13/2020
Pharmacological Classes
Price Statistics
The NADAC for ACYCLOVIR 200 MG/5 ML SUSP has been published 317 times since Sep 9, 2020, and over the history we have for it it has declined 82.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0764 per ML |
|---|---|
| All-time high | $0.4296 (Sep 16, 2020) |
| All-time low | $0.0583 (Nov 20, 2024) |
| 52-week high | $0.0869 |
| 52-week low | $0.0640 |
| Median price | $0.1511 |
| Average price | $0.1754 |
| Largest weekly change | -44.9% (Feb 21, 2024) |
| Weeks tracked | 317 |
| Tracking since | Sep 9, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the acyclovir market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
acyclovir market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACYCLOVIR 200 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for ACYCLOVIR 200 MG/5 ML SUSP, manufactured by ANI Pharmaceuticals, Inc., is $0.0764 per ML (NDC 70954018810), effective Sep 30, 2026.
How has the price of ACYCLOVIR 200 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for ACYCLOVIR 200 MG/5 ML SUSP has declined 82.2%. It has been tracked across 317 weekly CMS publications since Sep 9, 2020.
What are the highest and lowest recorded NADAC prices for ACYCLOVIR 200 MG/5 ML SUSP?
Since Sep 9, 2020, the NADAC for ACYCLOVIR 200 MG/5 ML SUSP has ranged from a low of $0.0583 (Nov 20, 2024) to a high of $0.4296 (Sep 16, 2020), with a median of $0.1511 per ML.
Are there cheaper alternatives to ACYCLOVIR 200 MG/5 ML SUSP?
No other NADAC-published product currently shares the active ingredient and strength of ACYCLOVIR 200 MG/5 ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ACYCLOVIR 200 MG/5 ML SUSP?
ACYCLOVIR 200 MG/5 ML SUSP (NDC 70954018810) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.